Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
179 | 52887 | 27.2 | 60% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
10 | 1074090 | VETERINARY SCIENCES//PARASITIOLOGY//AGRICULTURE, DAIRY & ANIMAL SCIENCE |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
434 | 15650 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
540 | 13989 | FLUOROQUINOLONES//CIPROFLOXACIN//QUINOLONES |
1013 | 9860 | CHLORAMPHENICOL//JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS//TETRACYCLINES |
2085 | 4774 | DIFFUSE PANBRONCHIOLITIS//AZITHROMYCIN//ROXITHROMYCIN |
2348 | 3955 | PHOSPHOLIPIDOSIS//2 DEOXYSTREPTAMINE//AMINOGLYCOSIDES |
2645 | 2993 | NITROFURANS//NITROFURAN METABOLITES//FURAZOLIDONE |
3158 | 1666 | GENTAMICIN//WEN PI TANG//GENTAMICIN INDUCED NEPHROTOXICITY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | Journal | 875 | 25% | 6% | 2990 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | Journal | 747 | 18% | 7% | 3860 |
3 | CHEMOTHERAPY-TOKYO | Journal | 363 | 89% | 0% | 166 |
4 | FLUOROQUINOLONES | Author keyword | 312 | 39% | 1% | 637 |
5 | CIPROFLOXACIN | Author keyword | 273 | 32% | 1% | 702 |
6 | CHEMOTHERAPY | Journal | 263 | 30% | 1% | 736 |
7 | AMINOGLYCOSIDES | Author keyword | 245 | 44% | 1% | 421 |
8 | QUINOLONES | Author keyword | 235 | 42% | 1% | 427 |
9 | GENTAMICIN | Author keyword | 209 | 32% | 1% | 533 |
10 | JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | Journal | 189 | 27% | 1% | 604 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FLUOROQUINOLONES | 312 | 39% | 1% | 637 | Search FLUOROQUINOLONES | Search FLUOROQUINOLONES |
2 | CIPROFLOXACIN | 273 | 32% | 1% | 702 | Search CIPROFLOXACIN | Search CIPROFLOXACIN |
3 | AMINOGLYCOSIDES | 245 | 44% | 1% | 421 | Search AMINOGLYCOSIDES | Search AMINOGLYCOSIDES |
4 | QUINOLONES | 235 | 42% | 1% | 427 | Search QUINOLONES | Search QUINOLONES |
5 | GENTAMICIN | 209 | 32% | 1% | 533 | Search GENTAMICIN | Search GENTAMICIN |
6 | FLUOROQUINOLONE | 185 | 41% | 1% | 347 | Search FLUOROQUINOLONE | Search FLUOROQUINOLONE |
7 | NORFLOXACIN | 152 | 46% | 0% | 250 | Search NORFLOXACIN | Search NORFLOXACIN |
8 | CHLORAMPHENICOL | 143 | 39% | 1% | 285 | Search CHLORAMPHENICOL | Search CHLORAMPHENICOL |
9 | ENROFLOXACIN | 135 | 47% | 0% | 211 | Search ENROFLOXACIN | Search ENROFLOXACIN |
10 | CEFEPIME | 134 | 55% | 0% | 168 | Search CEFEPIME | Search CEFEPIME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CIPROFLOXACIN | 693 | 32% | 3% | 1781 |
2 | FLUOROQUINOLONES | 651 | 46% | 2% | 1051 |
3 | QUINOLONES | 509 | 52% | 1% | 686 |
4 | INVITRO ACTIVITY | 456 | 49% | 1% | 676 |
5 | ANTIBIOTICS | 363 | 14% | 5% | 2420 |
6 | AMINOGLYCOSIDE ANTIBIOTICS | 350 | 49% | 1% | 517 |
7 | DNA GYRASE | 338 | 43% | 1% | 607 |
8 | ANTIBIOTIC RESIDUES | 310 | 81% | 0% | 184 |
9 | QUINOLONE | 292 | 55% | 1% | 365 |
10 | ENROFLOXACIN | 271 | 59% | 1% | 303 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 875 | 25% | 6% | 2990 |
2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 747 | 18% | 7% | 3860 |
3 | CHEMOTHERAPY-TOKYO | 363 | 89% | 0% | 166 |
4 | CHEMOTHERAPY | 263 | 30% | 1% | 736 |
5 | JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | 189 | 27% | 1% | 604 |
6 | INFECTION | 92 | 15% | 1% | 551 |
7 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 81 | 20% | 1% | 366 |
8 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 65 | 13% | 1% | 466 |
9 | JAPANESE JOURNAL OF ANTIBIOTICS | 65 | 72% | 0% | 51 |
10 | JOURNAL OF CHEMOTHERAPY | 62 | 16% | 1% | 368 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
DNA topoisomerases | 1996 | 1684 | 496 | 79% |
DNA topoisomerases: Structure, function, and mechanism | 2001 | 1280 | 184 | 81% |
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs | 2010 | 305 | 105 | 72% |
DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS | 1989 | 1842 | 134 | 66% |
Cellular roles of DNA topoisomerases: A molecular perspective | 2002 | 1137 | 111 | 50% |
Drugging Topoisomerases: Lessons and Challenges | 2013 | 96 | 137 | 56% |
Targeting DNA topoisomerase II in cancer chemotherapy | 2009 | 354 | 156 | 49% |
DNA gyrase, topoisomerase IV, and the 4-quinolones | 1997 | 693 | 174 | 67% |
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions | 2014 | 24 | 137 | 67% |
Topoisomerase I inhibitors: camptothecins and beyond | 2006 | 648 | 140 | 35% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BURNS TRAUMA CRIT CARE | 47 | 34% | 0.2% | 113 |
2 | ANTIINFECT DEV | 38 | 37% | 0.2% | 81 |
3 | VET PHARMACOL TOXICOL | 29 | 23% | 0.2% | 113 |
4 | FARMACEUT CHEM ANAL GENEESMIDDELEN | 28 | 53% | 0.1% | 37 |
5 | FARMACEUT WETEN PEN | 26 | 28% | 0.2% | 82 |
6 | CLIN PHARMACOTHER Y | 26 | 49% | 0.1% | 38 |
7 | UNITE PHARMACOL CELLULAIRE MOL | 26 | 41% | 0.1% | 48 |
8 | ANTI INFECT DEV | 24 | 57% | 0.1% | 28 |
9 | BIOELE OCHEM | 16 | 30% | 0.1% | 44 |
10 | VET DRUG IDUES | 15 | 45% | 0.0% | 26 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000004200 | INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS//MRSA |
2 | 0.0000003088 | STREPTOCOCCUS PNEUMONIAE//NEISSERIA MENINGITIDIS//COMMUNITY ACQUIRED PNEUMONIA |
3 | 0.0000001855 | NECROTIZING FASCIITIS//LYMPHEDEMA//GROUP A STREPTOCOCCI |
4 | 0.0000001553 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//SGLT2 INHIBITOR |
5 | 0.0000001395 | HUMAN SERUM ALBUMIN//CARDIOTOXICITY//BOVINE SERUM ALBUMIN |
6 | 0.0000001340 | TOXIC EPIDERMAL NECROLYSIS//STEVENS JOHNSON SYNDROME//DRUG HYPERSENSITIVITY |
7 | 0.0000001309 | PASTEURELLA MULTOCIDA//ACTINOBACILLUS PLEUROPNEUMONIAE//MYCOPLASMA BOVIS |
8 | 0.0000001231 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//AMERICAN JOURNAL OF HOSPITAL PHARMACY//BEERS CRITERIA |
9 | 0.0000001204 | STREPTOMYCES//O GLCNAC//JOURNAL OF ANTIBIOTICS |
10 | 0.0000001157 | JOURNAL OF BACTERIOLOGY//MOLECULAR MICROBIOLOGY//JOURNAL OF MOLECULAR BIOLOGY |